MedTrace Logo

Delivery of Self Training and Education for Stressful Situations-Telephone Version

NCT01502449 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2012-01-12

No results posted yet for this study

Summary

This study will evaluate a telephone-delivered cognitive-behavioral psychotherapy intervention designed for primary care treatment of combat-exposed service members with PTSD. The investigators will assess Posttraumatic Stress Disorder (PTSD) symptoms, mental health-related and occupational functioning, and symptoms of depression, anxiety, and somatization.

Conditions

Interventions

BEHAVIORAL

DESTRESS-T

Usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider, and care coordination

OTHER

Optimized Usual Care (OUC)

Optimized Usual Care is usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider (PCP), and care coordination.

Sponsors & Collaborators

  • Walter Reed National Military Medical Center

    collaborator FED

  • United States Department of Defense

    collaborator FED

  • US Department of Veterans Affairs

    collaborator FED

  • Uniformed Services University of the Health Sciences

    lead FED

Principal Investigators

  • COL Charles C. Engel, MD, MPH · Uniformed Services University of the Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01502449 on ClinicalTrials.gov